Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06074224 · ClinicalTrials.gov registry record · NA
Sleep Assessment: The Benefits of Identifying Sleep Disturbance Using a Sleep Questionnaire
A NA study of Sleep Disturbance, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 114
- Enrollment target
- 2
- Study locations
NCT06074224: Completed NA study of Sleep Disturbance, sponsored by University of Texas at Austin.
NCT06074224 is a NA study of Sleep Disturbance that has completed, run by University of Texas at Austin. The registered enrollment target is 114 participants, below the 176-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (35% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06074224, a NA study of Sleep Disturbance, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators are interested in measuring the influence of addressing sleep in the orthopedic setting. This includes assessing patient experience measures (satisfaction with the visit, perceived empathy, communication effectiveness) as well as greater engagement in their healthcare (patient activation). The investigators will also see what factors might be associated with sleep disturbance and if addressing sleep leads to an intervention such as cognitive behavioral therapy.
Primary Outcome
The Jefferson Scale of Patient's Perceptions of Physician Empathy includes five 7-point scale questions and higher scores indicated greater perceived clinician empathy.
Conditions Studied
Interventions
- OTHER Sleep assessment score
- OTHER No Score
Study Locations (2)
Texas
- University of Texas Health Austin (UTHA) - Austin
- University of Texas Health Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2023-12-01 |
| Phase | NA |
What the finished NCT06074224 record still lists
NCT06074224 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 176-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Sleep Disturbance appearing as the primary indexed condition, and to 2 interventions - of which Sleep assessment score is the first listed.
NCT06074224 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06074224 about?
NCT06074224 is a clinical study titled "Sleep Assessment: The Benefits of Identifying Sleep Disturbance Using a Sleep Questionnaire". The investigators are interested in measuring the influence of addressing sleep in the orthopedic setting. This includes assessing patient experience measures (satisfaction with the visit, perceived empathy, communication effectiveness) as well as greater engagement in their healthcare (patient acti...
What is the current status of trial NCT06074224?
This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2022-02-01. Estimated completion is 2023-12-01.
What conditions does trial NCT06074224 study?
This clinical trial studies the following conditions: Sleep Disturbance.
What interventions are being tested in trial NCT06074224?
The interventions under investigation include: Sleep assessment score (OTHER), No Score (OTHER).
Who is sponsoring clinical trial NCT06074224?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06074224 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disturbance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06074224's enrollment target sits among peer trials
114 21st of 56 higher than 36 of 56 other Sleep Disturbance trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Disturbance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Adjunctive Bright Light Therapy for Opioid Use Disorder
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia
RECRUITING · NA
-
Sleep Promotion Program Primary Care
RECRUITING · NA
-
VR-PMR for Post-Burn Symptoms
RECRUITING · NA
-
SPARK Healthy Sleep
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI